Fiona McLaren-Neil

h-index

Research activity per year

Fingerprint

Dive into the research topics where Fiona McLaren-Neil is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Article

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Keir, H. R., Long, M. B., Abo-leyah, H., Giam, Y. H., Vadiveloo, T., Pembridge, T., Hull, R. C., Delgado, L., Band, M., McLaren-Neil, F., Adamson, S., Lahnsteiner, E., Gilmour, A., Hughes, C., New, B. J., Connell, D., Dowey, R., Turton, H., Richardson, H. & Cassidy, D. & 20 others, Cooper, J., Suntharalingam, J., Diwakar, L., Russell, P., Underwood, J., Hicks, A., Dosanjh, D. P. S., Sage, B., Dhasmana, D., Spears, M., Thompson, A. A. R., Brightling, C., Smith, A., Patel, M., George, J., Condliffe, A. M., Shoemark, A., MacLennan, G., Chalmers, J. D. (Lead / Corresponding author) & STOP-COVID19 Investigators, 1 Dec 2022, In: The Lancet Respiratory Medicine. 10, 12, p. 1119-1128 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
8 Citations (Scopus)

67 Downloads (Pure)

McLaren-Neil, Fiona

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

McLaren-Neil, Fiona

Fingerprint

Collaborations and top research areas from the last five years

Research output

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial